United Lithium Announces Results from the 2025 Annual General Meeting of Shareholders
VANCOUVER, British Columbia, June 27, 2025 (GLOBE NEWSWIRE) — United Lithium Corp. ('United Lithium' or the 'Company') (CSE:
ULTH
; OTCQX:
ULTHF
; FWB:
0UL
) is pleased to announce the voting results from its annual general meeting of shareholders held on June 27, 2025 (the 'Meeting').
All directors nominated as listed in the information circular dated May 13, 2025, were elected, as shown in the following table below:
At the Meeting, the shareholders of the Company also approved the re-appointment of Dale Matheson Carr-Hilton LaBonte LLP as the auditor of the Company for the ensuing year and authorized the directors to fix their remuneration.
The total number of common shares of United Lithium represented by shareholders in person or by proxy at the Meeting was 4,789,956 common shares, representing 10.033% of the total issued and outstanding common shares at the record date for the Meeting.
On Behalf of The Board of Directors
'Scott Eldridge'
President, Chief Executive Officer and Director
Telephone: +1-604-428-6128
Email:
scott@unitedlithium.com
About United Lithium
United Lithium is an exploration & development company energized by the global demand for lithium. The Company is targeting lithium projects in politically safe jurisdictions with advanced infrastructure that allows for rapid and cost-effective exploration, development, and production opportunities.
The Company's consolidated financial statements and related management's discussion and analysis are available on the Company's website at
https://unitedlithium.com
or under its profile on SEDAR+ at
www.sedarplus.ca
.
The Canadian Securities Exchange has not approved nor disapproved the contents of this news release and does not accept responsibility for the adequacy or accuracy of this release.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
3 hours ago
- Business Wire
Rocket Lab Completes Record Launch Turnaround From Launch Complex 1, Successfully Deploys 68 th Electron Mission
MAHIA, New Zealand--(BUSINESS WIRE)--Rocket Lab Corporation (Nasdaq: RKLB) ('Rocket Lab' or 'the Company'), a global leader in launch services and space systems, today successfully launched its 68th Electron rocket to deploy a single satellite to space for a confidential commercial customer. The mission was the second of two launches from the same launch site in less than 48 hours, a new launch record for the Company as it continues to deliver dedicated, repeatable and reliable access to space for satellite operators. The 'Symphony In The Stars' mission lifted-off from Rocket Lab Launch Complex 1 in Mahia, New Zealand on June 28 th (7:08 p.m./07:08 UTC) to deploy a single spacecraft to a 650km circular Earth orbit. The mission was the first of two dedicated launches for the new customer on Electron booked less than four months ago, with a second mission scheduled before the end of 2025. Rocket Lab has now completed four launches in June for commercial satellite constellation operators, underscoring Electron's consistent performance and rapid deployment capabilities as the world's leading small launcher: the 'Full Stream Ahead' mission on June 3 rd; 'The Mountain God Guards' mission on June 11 th; 'Get The Hawk Outta Here' launched on June 26 th UTC, and today's 'Symphony In The Stars' mission. Rocket Lab Founder and CEO, Sir Peter Beck, says: 'Electron has demonstrated once again that it is the gold standard for responsive and reliable space access for small satellites. The future of space is built on proven performance, and Electron continues to deliver against a stacked launch manifest this year. Congratulations to the team on achieving its fastest launch turnaround yet between two missions from Launch Complex 1. This launch was also a quick-turn mission to meet our customer's mission requirements, and we're looking forward to doing it again later this year.' 'Symphony In The Stars' was Rocket Lab's tenth Electron mission of 2025 and its 68th launch overall. With 100% mission success so far this year, Electron continues to deliver reliable deployment amid an increasing launch cadence and rapid contract-to-launch timelines. Launch images: About Rocket Lab Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufacture, spacecraft components, and on-orbit management solutions that make it faster, easier, and more affordable to access space. Headquartered in Long Beach, California, Rocket Lab designs and manufactures the Electron small orbital launch vehicle, a family of spacecraft platforms, and the Company is developing the large Neutron launch vehicle for constellation deployment. Since its first orbital launch in January 2018, Rocket Lab's Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered over 200 satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab's spacecraft platforms have been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a third launch pad in Virginia. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the 'Securities Act') and Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development, operational expansion and business strategy are forward-looking statements. The words 'believe,' 'may,' 'will,' 'estimate,' 'potential,' 'continue,' 'anticipate,' 'intend,' 'expect,' 'strategy,' 'future,' 'could,' 'would,' 'project,' 'plan,' 'target,' and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the 'SEC'), accessible on the SEC's website at and the Investor Relations section of our website at which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
Miami Herald
7 hours ago
- Miami Herald
CoTec Holdings Corp. Announces Annual and Special Meeting Results
VANCOUVER, BC / ACCESS Newswire / June 27, 2025 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) (the "Company") is pleased to announce that all resolutions were passed by requisite majority at its annual and special meeting of shareholders held earlier today in virtual format. The seven incumbent directors, Julian Treger, Raffaele (Lucio) Genovese, Tom Albanese, Margot Naudie, Sharon Fay, Erez Ichilov and Robert Harward were re-elected to the Board by shareholders. The shareholders also approved the re-appointment of PricewaterhouseCoopers LLP as auditors of the Company for the ensuing year and the Company's amended and restated omnibus equity incentive plan. About CoTecCoTec is a publicly traded investment issuer listed on the TSXV and the OTCQB and trades under the cymbol CTH and CTHCF respectively. CoTec is a forward-thinking resource extraction company committed to revolutionizing the global metals and minerals industry through innovative, environmentally sustainable technologies and strategic asset acquisitions. With a mission to drive the sector toward a low-carbon future, CoTec employes a dual approach: investing in disruptive mineral extraction technologies that enhance efficiency and sustainability while applying these technologies to undervalued mining assets to unlock their full potential. By focusing on recycling, waste mining, and scalable solutions, the Company accelerates the production of critical minerals, shortens development timelines, and reduces environmental impact. CoTec's strategic model delivers low capital requirements, rapid revenue generation, and high barriers to entry, positioning it as a leading mid-tier disruptor in the commodities sector. For more information, please visit For further information, please contact:Braam Jonker - (604) 992-5600 Forward-Looking Information Cautionary StatementStatements in this press release regarding the Company and its investments which are not historical facts are "forward-looking statements" that involve risks and uncertainties, including statements relating to management's expectations with respect to its current and potential future investments, the value of such investments and the benefits to the Company which may be implied from such statements. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. Actual results in each case could differ materially from those currently anticipated in such statements. For further details regarding risks and uncertainties facing the Company please refer to "Risk Factors" in the Company's filing statement dated April 6, 2022, a copy of which may be found under the Company's SEDAR+ profile at Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. SOURCE: CoTec Holdings Corp.
Business Upturn
8 hours ago
- Business Upturn
University of Bridgeport and Goodwin University Revolutionize Regenerative Medicine Training Program Forming Strategic Alliance with Globally Recognized TulsiHub Institute
BRIDGEPORT, CT, June 27, 2025 (GLOBE NEWSWIRE) — The two leading academic institutions have joined forces with TulsiHub Institute, the premier provider of advanced CE certified regenerative medicine certification programs, to transform medical education standards across regenerative medicine and cellular therapy disciplines. This innovative alliance positions both universities as pioneers in cutting-edge healthcare training while establishing new industry standards for professional medical certifications and continuing medical education in the rapidly expanding regenerative healthcare sector. Universities Pioneer Advanced Regenerative Medicine Education Partnership With the global regenerative medicine market expected to expand from $60 billion in 2023 to over $375 billion by 2031, this exponential growth creates significant demand for qualified practitioners capable of delivering advanced regenerative treatments including stem cell therapy, tissue engineering, and cellular therapy applications. The collaboration establishes both institutions as pioneers in advanced healthcare education, directly responding to the urgent need for comprehensive regenerative medicine training in the United States. This partnership addresses critical gaps in medical education across multiple regenerative medicine disciplines, including stem cell therapy, gene therapy, tissue engineering, cellular therapy, PRP (Platelet Rich Plasma) therapy, EBOO Therapy, Exosome therapy, Prolotherapy, and Shockwave therapy. 'It's a call to shape the very future of medicine,' remarked President Mark E. Scheinberg. 'We are excited to help forge a new generation of healthcare professionals who will redefine what's possible in patient care.' First-of-Its-Kind CE Certified Regenerative Medicine Training Program in the U.S. Through this strategic alliance, students gain access to the first intensive and comprehensive CE certified regenerative medicine training program of this caliber in the United States. The program features 12 specialized medical courses delivered through a unique 8-to-12-week intensive training methodology that combines theoretical medical knowledge with extensive practical training, ensuring certified healthcare professionals achieve clinical competency in cutting-edge regenerative medicine techniques. The evidence-based curriculum provides healthcare professionals with comprehensive on-site instruction under expert medical supervision with extensive hands-on experience. This approach ensures graduates possess both theoretical understanding and practical expertise in regenerative medicine applications, responding to urgent market demand from healthcare professionals seeking advanced training in regenerative therapies without geographic barriers. Students benefit from generous scholarships provided by TulsiHub Institute, along with access to seed funding opportunities of US$100,000 for establishing their own regenerative medicine clinics, and favorable lifetime discounts on medical consumables to support the ongoing success of their practices. This comprehensive support system addresses the practical implementation challenges newly certified practitioners face, providing essential financial resources to successfully transition from training to clinical application. 'This strategic collaboration establishes our institution as a leader in advanced healthcare education while reinforcing our dedication to equipping students and medical professionals with innovative training programs that address evolving industry requirements,' said University of Bridgeport President Danielle Wilken, Ed.D. Global Leader in Regenerative Medicine Certification TulsiHub Institute consortium maintains an exceptional 98% certification success rate while delivering internationally recognized credentials to medical professionals across 25 countries worldwide. As the gold standard in CE certified regenerative medicine certification, they have successfully certified over 500 healthcare professionals through comprehensive training programs. 'This partnership marks the first and only intensive and comprehensive CE certified regenerative medicine training program of this caliber available in the United States. We are responding to urgent market demand from healthcare professionals seeking advanced training in regenerative therapies without geographic barriers,' said Dr. Natasha Macleay, CEO of TulsiHub Institute. This institution also offers comprehensive certification programs equipping students with the latest advancements in longevity, preventive care, anti-aging protocols, in specialized areas like Dermatology, Orthopedics, Oncology Care, and Dentistry supported by a world-class faculty, advanced research facilities, and a dynamic community for collaboration. Academic Excellence and Leadership To ensure the highest standard in academic oversight, the program involves key University of Bridgeport leadership, including: Elena Cahill, JD, VP of Innovation, Strategy, and Advancement. Dr. Michael Ciolfi, Dean of the College of Health and Sciences; and Dr. James Lehman, Director of Health Sciences Postgraduate Education. The combined expertise of these individuals along with Raghav Goyal Co CEO of TulsiHub ensures the program maintains rigorous academic standards while addressing current industry requirements. Program Eligibility The program welcomes medical students, practicing physicians, nurses, chiropractors, and other healthcare professionals seeking specialized and CE certified regenerative medicine expertise. Eligibility encompasses MD, DO, DC, ND, DPM, PA, APRN degree holders, as well as RN, LPN, NP, CRNA, CNS, and CNM professionals. Visit to learn more about the courses and our partnership with the University of Bridgeport and Goodwin University. For media inquiries, please contact: Email: [email protected] Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
